These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8102931

  • 1. Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.
    Brooks DP, Short BG, Cyronak MJ, Contino LC, DiCristo M, Wang YX, Ruffolo RR.
    Br J Pharmacol; 1993 Jun; 109(2):581-6. PubMed ID: 8102931
    [Abstract] [Full Text] [Related]

  • 2. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D, Jovovic D, Mihailovic-Stanojevic N, Miloradovic Z, Naumovic R, Dimitrijevic J, Maksic N, Djukanovic L.
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
    Van den Branden C, Gabriels M, Vamecq J, Vanden Houte K, Verbeelen D.
    Nephron; 1997 Sep; 77(3):319-24. PubMed ID: 9375827
    [Abstract] [Full Text] [Related]

  • 7. Effect of long-term carvedilol therapy on renal function in essential hypertension.
    Tomita K, Marumo F.
    J Cardiovasc Pharmacol; 1992 Sep; 19 Suppl 1():S97-101. PubMed ID: 1378158
    [Abstract] [Full Text] [Related]

  • 8. [Effects of carvedilol in rats with induced chronic kidney failure].
    Rodríguez Pérez JC, Cabrera JJ, Anabitarte A, Plaza ML, Losada A, García Suárez P, Afonso JL.
    Nefrologia; 2001 Sep; 21(1):52-8. PubMed ID: 11344962
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension.
    Miki S, Masumura H, Kaifu Y, Yuasa S.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 4():S62-8. PubMed ID: 1721982
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of carvedilol on renal function.
    Dupont AG.
    Eur J Clin Pharmacol; 1990 Sep; 38 Suppl 2():S96-100. PubMed ID: 1974513
    [Abstract] [Full Text] [Related]

  • 18. Carvedilol and the kidney.
    Dupont AG.
    Clin Investig; 1992 Sep; 70 Suppl 1():S127-31. PubMed ID: 1350479
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM.
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [Abstract] [Full Text] [Related]

  • 20. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    McTavish D, Campoli-Richards D, Sorkin EM.
    Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.